Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel43

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program and early access program with cabazitaxel plus prednisone in patients with metastatic castration-resistant prostate cancer (mcrpc) previously treated with docetaxel15

Views

Views
April 20252
May 20251
June 20250
July 202511
August 20250
September 20251
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States3
United Kingdom2
Spain1
Poland1
Senegal1
 

Top cities views

Views
Blumenau1
Brusque1
Campos dos Goytacazes1
Council Bluffs1
Dakar1
Dallas1
Dudley1
Grand Prairie1
Harringay1
Jupi1